1. Home
  2. LNTH vs CGNX Comparison

LNTH vs CGNX Comparison

Compare LNTH & CGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNTH
  • CGNX
  • Stock Information
  • Founded
  • LNTH 1956
  • CGNX 1981
  • Country
  • LNTH United States
  • CGNX United States
  • Employees
  • LNTH N/A
  • CGNX N/A
  • Industry
  • LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • CGNX Industrial Machinery/Components
  • Sector
  • LNTH Health Care
  • CGNX Industrials
  • Exchange
  • LNTH Nasdaq
  • CGNX Nasdaq
  • Market Cap
  • LNTH 6.3B
  • CGNX 7.0B
  • IPO Year
  • LNTH 2015
  • CGNX 1989
  • Fundamental
  • Price
  • LNTH $89.29
  • CGNX $35.77
  • Analyst Decision
  • LNTH Strong Buy
  • CGNX Buy
  • Analyst Count
  • LNTH 6
  • CGNX 12
  • Target Price
  • LNTH $132.67
  • CGNX $47.08
  • AVG Volume (30 Days)
  • LNTH 1.0M
  • CGNX 1.2M
  • Earning Date
  • LNTH 11-06-2024
  • CGNX 02-13-2025
  • Dividend Yield
  • LNTH N/A
  • CGNX 0.89%
  • EPS Growth
  • LNTH 304.57
  • CGNX N/A
  • EPS
  • LNTH 6.02
  • CGNX 0.51
  • Revenue
  • LNTH $1,496,799,000.00
  • CGNX $881,501,000.00
  • Revenue This Year
  • LNTH $19.64
  • CGNX $10.30
  • Revenue Next Year
  • LNTH $4.38
  • CGNX $11.71
  • P/E Ratio
  • LNTH $14.83
  • CGNX $70.22
  • Revenue Growth
  • LNTH 24.15
  • CGNX 0.14
  • 52 Week Low
  • LNTH $50.20
  • CGNX $34.79
  • 52 Week High
  • LNTH $126.89
  • CGNX $53.13
  • Technical
  • Relative Strength Index (RSI)
  • LNTH 44.02
  • CGNX 33.76
  • Support Level
  • LNTH $91.20
  • CGNX $35.28
  • Resistance Level
  • LNTH $96.46
  • CGNX $37.63
  • Average True Range (ATR)
  • LNTH 2.89
  • CGNX 1.13
  • MACD
  • LNTH 0.54
  • CGNX -0.25
  • Stochastic Oscillator
  • LNTH 26.33
  • CGNX 9.96

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

About CGNX Cognex Corporation

Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's own cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. ID products read codes that have been applied to items during the manufacturing process. Cognex generates the maximum proportion of its sales in the United States and Europe.

Share on Social Networks: